openPR Logo
Press release

Global Gastroesophageal Cancer Drugs Market US$ 10.9 Billion by 2023, Trends and Forecast

05-08-2018 03:00 PM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Global Gastroesophageal Cancer Drugs Market US$ 10.9 Billion

The global gastroesophageal cancer drugs market to attain US$ 10.9 Billion by 2023, growing at a CAGR of 18.1% over the forecast period.

The most common types of esophageal cancer are squamous cell carcinoma and adenocarcinoma. Smoking and heavy alcohol use increase the risk of esophageal squamous cell carcinoma. Gastroesophageal reflux disease and Barrett esophagus may increase the risk of esophageal adenocarcinoma. Esophageal cancer is often diagnosed at an advanced stage because there are no early signs or symptoms.

Visit gastroesophageal cancer drugs market by drug class (angiogenesis inhibitors, CTLA4 inhibitors, cytotoxic agents, HER2 inhibitors, MMP9 inhibitors, PD1 inhibitors, PDL1 inhibitors); by geography and forecast 2015-2023 at https://www.ihealthcareanalyst.com/report/gastroesophageal-cancer-drugs-market/

The global gastroesophageal cancer drugs market research report provides market size (Revenue US$ Million 2015 to 2023), market share analysis, growth trends and forecast (CAGR%, 2018 to 2023). The global gastroesophageal cancer market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global gastroesophageal cancer market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global gastroesophageal cancer market and profiled in this report include Astellas Pharma, Bayer HealthCare, BeiGene, Boston Biomedical, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Gilead Sciences, LSK BioPharma, Merck KGaA, Merck Serono, Ono Pharmaceutical, Pfizer, Servier Laboratories, Shionogi, Sumitomo Dainippon Pharma, and Taiho Oncology.

1. Drug Class
1.1. Angiogenesis inhibitors
1.2. CTLA4 inhibitors
1.3. Cytotoxic agents
1.4. HER2 inhibitors
1.5. MMP9 inhibitors
1.6. PD1 inhibitors
1.7. PDL1 inhibitors

2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.3. Asia Pacific (Japan, China, India, Rest of APAC)
2.4. Latin America (Brazil, Mexico, Rest of LA)
2.5. Rest of the World

3. Company Profiles
3.1. Astellas Pharma
3.2. Bayer HealthCare
3.3. BeiGene
3.4. Boston Biomedical
3.5. Bristol-Myers Squibb
3.6. Celgene
3.7. Daiichi Sankyo
3.8. Gilead Sciences
3.9. LSK BioPharma
3.10. Merck KGaA
3.11. Merck Serono
3.12. Ono Pharmaceutical
3.13. Pfizer
3.14. Servier
3.15. Shionogi
3.16. Sumitomo Dainippon Pharma
3.17. Taiho Oncology

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/gastroesophageal-cancer-drugs-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Gastroesophageal Cancer Drugs Market US$ 10.9 Billion by 2023, Trends and Forecast here

News-ID: 1043018 • Views:

More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/ Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5.5 Billion by 2025
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and Services Market to US$ 73.2 Billion by 2023
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by

All 5 Releases


More Releases for Rest

An APIOps Platform , REST API Development
The pandemic's pandemonium served as a lesson in the value of adaptability, composability, and flexibility for both organizations and their ingrained technologies. Additionally, the rapid digitization of the world has made international connectivity more crucial than ever. Both of these domains benefit from API technology, which will make them even more crucial over the coming year. The user experience, centralization, and automated delivery of new APIs with integrated testing, security,
Livpure Launches Back Rest Cushion
Livpure Sleep is one the flagship brands of the SAR group. A company with a fast-paced growth in corporate India and a valued legacy, Livpure has swooped the sleeping solutions market and with a wide range of smart and innovative products. Livpure understands consumer’s need for comfort and sleep. Livpure, a manufacturer of water purifiers, air conditioners, air coolers, air purifiers, and other home-focused smart solutions, has jumped into the
Compart Goes REST API
DocBridge© Pilot 3.8, the new version of the output management software for cost-optimized Omnichannel customer communication, is now available. The most important innovation of the current release is an open programming interface based on the REST technology (API), which allows the user an even better integration of DocBridge© Pilot into his existing document and output management structures. Without time-consuming scripting, functions and data of DocBridge© Pilot can be retrieved via URLs
Agrochemicals Market in Rest of World
ReportsWorldwide has announced the addition of a new report title Rest of World: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports. The report “Rest of World: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG)
Rest Room Courtesy Is Still Appreciated
Respecting strangers is common courtesy; at least it should be. Kudos to those who respects others’. Historically, restroom courtesy has been engrained in ethics of social responsibility. After all, since grade school, most people have learned the value of picking up behind themselves, when using public rest rooms. Yet unfortunately, there are still countless people who lack rest room courtesy. As a commercial cleaning and building maintenance service provider, too often, Allen Maintenance
Savvy Rest Is Now GOTS Certified
May 25, 2011, Charlottesville, Virginia -- Savvy Rest, Central Virginia manufacturer of organic mattresses and bedding, is now a GOTS-certified company. GOTS stands for Global Organic Textile Standard, and it means that Savvy Rest’s manufacturing facility has passed the most demanding organic requirements a product or manufacturer can meet. GOTS certification ensures that organic textiles have been responsibly harvested, manufactured and labeled. “While any business can sell products that contain some